AARD•benzinga•
B of A Securities Initiates Coverage On Aardvark Therapeutics with Buy Rating, Announces Price Target of $22
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 10, 2025 by benzinga